PDG12- CLINICAL BENEFITS AND COST-OFFSETS OF COMBINATION THERAPY WITH NATEGLINIDE PLUS METFORMIN VERSUS METFORMIN ALONE IN DIABETES IN THE NETHERLANDS
Sep 1, 2001, 00:00
10.1016/S1098-3015(11)71749-1
https://www.valueinhealthjournal.com/article/S1098-3015(11)71749-1/fulltext
Title :
PDG12- CLINICAL BENEFITS AND COST-OFFSETS OF COMBINATION THERAPY WITH NATEGLINIDE PLUS METFORMIN VERSUS METFORMIN ALONE IN DIABETES IN THE NETHERLANDS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71749-1&doi=10.1016/S1098-3015(11)71749-1
First page :
Section Title :
Open access? :
No
Section Order :
263